Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
U.S. intelligence officials informed senators about Chinese pharmaceutical firm WuXi AppTec transferring U.S. intellectual property to Beijing without consent. Concerns arise about compromised IP, potential criminal charges, and implications for the BIOSECURE Act. The news has sparked reactions within the industry, with some urging caution and legal action.
Whatโs Congress going to do with WuXi? That and more in The Readout newsletter. https://t.co/qlDLAysisq
Report claims US intelligence services advised the authors of the #BIOSECUREAct that @WuXi_AppTec shared confidential data on US clients with the Chinese government https://t.co/7qMJif9oMo
News about WuXi AppTec stealing IP is very concerning, glad I only work with completely distinct WuXi Biologics! ๐ https://t.co/8Xfrhxdft1